Edition:
United States

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

21.57USD
15 Dec 2017
Change (% chg)

$-0.09 (-0.42%)
Prev Close
$21.66
Open
$21.70
Day's High
$22.05
Day's Low
$21.54
Volume
1,049,751
Avg. Vol
152,577
52-wk High
$24.50
52-wk Low
$10.44

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 24.14 -0.277
Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
FY 2016 Dec '16 6.27 -0.385
Sep '16 3.45 -0.404
Jun '16 3.09 -0.393
Mar '16 2.22 -0.444
FY 2015 Dec '15 1.99 -0.390
Sep '15 1.94 -0.412
Jun '15 2.04 -0.217
Mar '15 1.74 -0.219
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 10.10 15.00 0.60 9.20
Quarter Ending Mar-18 4 18.53 25.80 14.73 --
Year Ending Dec-17 7 55.74 61.00 45.20 24.00
Year Ending Dec-18 7 67.91 104.60 44.11 25.15
Earnings (per share)
Quarter Ending Dec-17 7 -0.43 -0.25 -0.70 -0.40
Quarter Ending Mar-18 4 -0.22 -0.01 -0.33 --
Year Ending Dec-17 7 -1.62 -1.43 -1.90 -1.75
Year Ending Dec-18 7 -1.53 -0.42 -2.69 -2.35
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) 16.30 122.78 5.95
Price to Book (MRQ) 17.59 23.45 5.68
Price to Tangible Book (MRQ) 19.32 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 78.82 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 599.02 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 372.36 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.29 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 3.47 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 5.28 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -113.16 -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -116.57 -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -113.68 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -113.64 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 651,551 22,314,532 851,801,741
Net Income/Employee (TTM) -740,423 -1,997,855 99,542,701
Receivable Turnover (TTM) 2.50 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.18 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -19.92 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -23.82 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -85.62 -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 95.06 156.83 --
EPS (TTM) % 66.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.20 2.36 71 94
13 Week 24.61 16.43 81 75
26 Week 58.60 44.22 87 59
52 Week 85.31 56.65 83 58
YTD 96.27 64.22 87 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.71%
# of Holders: 154
Total Shares Held: 30,230,964
3 Mo. Net Change: 2,217,027
# New Positions: 28
# Closed Positions: 19
# Increased Positions: 83
# Reduced Positions: 49
# Net Buyers: 34
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.